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ABSTRACT 
In patients with myotonic dystrophy (MD), impairment of the conduction system is a common and progressive find-
ing. However, only a few cases of MD with cardiomyopathy have been reported. Herein we report a case of MD with 
progressive non-ischemic cardiomyopathy and severe electrocardiographic abnormalities. (Korean Circ J 2009;39:340-
342) 
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Introduction 
 
Myotonic dystrophy (MD) is an inherited disorder 
transmitted in an autosomal dominant fashion.
1) In MD, 
cardiac complications are the second most common 
cause of death in up to 30% of patients.
2) The cardiac 
involvement in patients with MD is usually character-
ized by arrhythmias, mainly due to conduction system ab-
normalities and an increased risk of sudden death. How-
ever, the occurrence of clinical myocardial disease ap-
pears to be rare, with only occasional reports of cardio-
myopathy, and little is known about the clinical course 
as it relates to involvement of the myocardium.
3) 
 
Case 
 
A 48-year-old male patient with a 10-year history of 
MD was referred for evaluation of an abnormal electro-
cardiogram (EKG). He had no subjective symptoms. MD 
was confirmed by rectus femoralis muscle biopsy that 
showed atrophy and degenerated fibers with internal nu-
clei, consistent with a myotonic myopathy (Fig. 1A). Elec-
tromyography showed myotonic discharges in several 
muscles. The patient had four uncles who all died be-
cause of myopathic disease before 50 years of age. The 
patient had a 5-year-old niece with MD and cardiac in-
volvement. The patient’s daughter had a sudden death at 
18 years of age. 
The clinical examination revealed signs of classic MD. 
He had premature balding and had a characteristically 
thin face, hand myotonia, and bilateral weakness of the 
lower extremities. His blood pressure and heart rate were 
110/80 mmHg and 57/min, respectively. An initial 
12-lead EKG showed first-degree atrioventricular block 
(PR interval, 220 msec) and intraventricular conduction 
delay (QRS duration, 142 msec) (Fig. 1B). The serum cre-
atine kinase was mildly elevated, but the creatine kinase-
MB isoenzyme and troponin T levels were normal. No 
significant arrhythmias were observed on the initial 24-
hour Holter monitoring. However, an inappropriate 
heart rate (83/min) response with suspicious atrioven-
tricular block at stage 4 was observed on the exercise 
treadmill test. Initial transthoracic echocardiography 
(TTE) demonstrated hypokinesia of the inferior wall with 
mild left ventricular systolic dysfunction (ejection frac-
tion, 45%). There were no signs of ischemic disease by 
coronary angiography; there was no fat infiltration or 
fibrosis demonstrated on cardiac MRI (Fig. 1C). 
On the 1-year follow-up evaluation, intermittent left 
bundle branch block was observed on 24-hour Holter 
monitoring (Fig. 1D), and more aggravated regional wall 
motion abnormalities (hypokinesia of the anterolateral 
and inferior walls) were shown on TTE (ejection fraction, 
40%) with dyspnea on exertion New York Heart Asso-
ciation. A permanent pacemaker insertion was consid-
ered to prevent sudden death based on American Col-
lege of Cardiology/American Heart Association guide-
lines. 
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Discussion 
 
While cardiac involvement (CI) in MD is usually char-
acterized by arrhythmias (conduction abnormalities and 
tachyarrhythmias), myocardial damage with symptoms of 
heart failure is rare because CI is mainly due to selective 
degeneration of the infra-nodal conduction system.
3-5) 
On histologic evaluation, CI in MD involves interstitial 
myocardial fibrosis and fatty infiltration.
6) Interestingly, 
in the case described herein, there were no significant 
arrhythmias on EKG, no fibro-lipomatous changes, and 
no evidence of myocardial ischemia on cardiac MRI. 
However, the initial and follow-up EKGs showed de-
creased left ventricular systolic function and extended 
regional wall motion abnormalities. Therefore, serial 
EKGs may be a more useful imaging tool than CT or 
MRI for earlier detection of myocardial involvement in 
asymptomatic patients with MD.   
In primary MD patients, cardiac involvement is the 
second most common cause of death.
2) Atrioventricular 
block and ventricular tachyarrhythmia are considered to 
be the main cause of sudden death in patients with M-
D.
7) Several studies have recommended that Holter mo-
nitoring should be performed on a regular basis.
8)9) Re-
cent pacing guidelines have recognized that asymptomat-
ic conduction abnormalities in MD may warrant spe-
cial consideration for pacing.
10) In the present case, the 
patient showed non-specific findings on initial Holter 
monitoring, but treadmill testing showed a significant 
arrhythmia and an inappropriate heart rate. Progressive 
conduction abnormalities with aggravated cardiomyo-
pathy were observed on subsequent follow-up examina-
tions. 
We therefore suggest that comprehensive evaluation 
with treadmill testing and an EKG may be beneficial for 
patients with primary MD, even when asymptomatic, to 
identify non-ischemic cardiomyopathy in an effort to de-
termine the appropriate time for pacemaker insertion and 
prevention of life-threatening complications. 
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